icon-folder.gif   Conference Reports for NATAP  
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
Short Duration Treatment with AL-335 and Odalasvir, with or without Simeprevir, in Treatment Naïve Patients with Hepatitis C Infection with or without Cirrhosis
  Reported by Jules Levin
EASL 2017 April 19-22 Amsterdam Netherlands
Ed Gane,1 Catherine Stedman,2 Matthew McClure,3 David Apelian,4 Chris Westland,3 Jennifer Vuong,3 Megha Patel,3 Thomas Kakuda,3 Sushmita Chanda,3 Lawrence Blatt,3 Leo Beigelman,3 David Smith,3 John Fry3
1University of Auckland, Auckland, New Zealand; 2University of Otago, Christchurch, New Zealand; 3Alios BioPharma Inc., part of the Janssen Pharmaceutical Companies, South San Francisco, CA, USA; 4Achillion, New Haven, CT, USA